Insulin resistance is considered the major mechanism in the development and progression of MASLD/MASH as a result of impaired insulin signaling that leads to increase intracellular fatty acid-derived metabolites such as diacylglycerol, fatty acyl CoA or ceramides (6). The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.